Non-small Cell Lung Cancer Stage IIIB Clinical Trial
Official title:
Influence of Neoadjuvant Chemoimmunotherapy on Treatment Response in Stage IIIA- N2IIIB Non-small Cell Lung Cancer
to explore the impact of preoperative neoadjuvant immunotherapy on perioperative outcomes and long-term prognosis of locally advanced NSCLC in the real world
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT02035683 -
PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy
|
N/A | |
| Terminated |
NCT00766246 -
Phase II Avastin Trial for Stage IIIB/IV NSCLC
|
Phase 2 | |
| Terminated |
NCT03386929 -
Survival Prolongation by Rationale Innovative Genomics
|
Phase 1/Phase 2 | |
| Recruiting |
NCT01493011 -
Chemotherapy Combined With Whole-body Hyperthermia to Treat Stage IIIB/IV Non Small Cell Lung Cancer
|
N/A | |
| Terminated |
NCT01348126 -
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05919264 -
FOG-001 in Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05713006 -
Alectinib Pharmacokinetic in Patients With NSCLC
|
Phase 1/Phase 2 | |
| Terminated |
NCT01798485 -
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
|
Phase 3 | |
| Active, not recruiting |
NCT01405586 -
MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer
|
Phase 3 | |
| Withdrawn |
NCT03628144 -
Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer
|
Phase 2 | |
| Completed |
NCT02176369 -
Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial
|
Phase 2 | |
| Active, not recruiting |
NCT03611738 -
Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC
|
Phase 1 | |
| Completed |
NCT01473563 -
A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)
|
Phase 2 | |
| Active, not recruiting |
NCT01656551 -
MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer
|
Phase 3 | |
| Not yet recruiting |
NCT03532698 -
Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)
|
||
| Not yet recruiting |
NCT03543683 -
Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC
|